These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27068172)

  • 21. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
    World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus: Clinical issues.
    Spechler SJ
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):1-7. PubMed ID: 21112493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus and Barrett's carcinoma.
    von Rahden BH; Stein HJ; Siewert JR
    Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenesis of esophageal cancer from reflux esophagitis].
    Kawano T; Nakajima Y; Kawada K
    Nihon Rinsho; 2016 Aug; 74(8):1393-1400. PubMed ID: 30562449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
    Yang L; Lu X; Nossa CW; Francois F; Peek RM; Pei Z
    Gastroenterology; 2009 Aug; 137(2):588-97. PubMed ID: 19394334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between Helicobacter pylori Eradication and Barrett's Esophagus Elongation.
    Hashigami K; Iwaya Y; Nagaya T; Hara D; Hirayama A; Okamura T; Akamatsu T; Umemura T
    Digestion; 2024; 105(3):186-191. PubMed ID: 38290483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
    Yang L; Francois F; Pei Z
    Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of GERD, esophagitis, Barrett's esophagus, and esophageal adenocarcinoma after bariatric surgery.
    Bevilacqua LA; Obeid NR; Yang J; Zhu C; Altieri MS; Spaniolas K; Pryor AD
    Surg Obes Relat Dis; 2020 Nov; 16(11):1828-1836. PubMed ID: 32711954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
    Fabian T; Leung A
    Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
    Gopal DV; Lieberman DA; Magaret N; Fennerty MB; Sampliner RE; Garewal HS; Falk GW; Faigel DO
    Dig Dis Sci; 2003 Aug; 48(8):1537-41. PubMed ID: 12924649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Schneider JL; Corley DA
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett's esophagus.
    Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
    J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.